Luciano Ibba

37PUBLICATIONS
65CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineChiropracticPain
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jul 25, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

|Jul 03, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

|Jun 26, 2026
Dose Adjustment of JAK Inhibitors for the Management of Moderate-to-Severe Atopic Dermatitis: A Single-Centre Retrospective Study.

|Mar 23, 2026
Lebrikizumab After Multiple Prior Advanced Therapies in Moderate-To-Severe Atopic Dermatitis: A Real-World Case Series.

Giovanni Paolino, Matteo Riccardo Di Nicola, Luciano Ibba

|Jan 28, 2026
Tildrakizumab in Managing Psoriasis with Involvement of Difficult-to-Treat Areas: A Multicenter Real-Life Retrospective Study.

Ruggero Cascio Ingurgio, Angela Alfano, Elena Matteodo

|Jan 28, 2026
JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology.

Giulio Foggi, Francesco D'Oria, Costanza Falcidia

Pageof 7

Frequent Collaborators

26 joint publications

Luigi Gargiulo

16 joint publications

Antonio Costanzo

13 joint publications

Mario Valenti

9 joint publications

Matteo Bianco